Health Canada
Symbol of the Government of Canada

Common menu bar links

About Health Canada

Access to Information Requests Completed - April 2015

The following is a list of Access to Information requests processed by Health Canada. The list is not all-inclusive. The list contains requests completed for which documents have been retrieved or treated. The list is provided in chronological order, by month and year, and by request number. (Requests focusing on personal information or third party proprietary information are not included.)

If you wish to obtain a copy of the records released in response to these requests informally, you may contact the Access to Information and Privacy Division.

For the month of April 2015
Request # Summary of Requests Status of Completed Request Number of Pages Disclosed
A-2013-00483 Information related to the annual cost for all health services provided to Manitoba through the First Nations and Inuit Health Branch funding (Apr. 1, 1998 to July 31, 2013) All disclosed 2
A-2013-01113 Information on the number of complaints concerning electronic cigarettes received by Health Canada and adverse reaction reports (Jan. 1, 2009 to Dec. 16, 2013) Disclosed in part 481
A-2014-00531 Adverse Reaction Report (AER) for Creon. Report number: 000584748. Disclosed in part 15
A-2014-00684 Any records related to the medical marihuana about concerns HC heard from law enforcement officials, fire departments, and municipal officers across the country Disclosed in part 855
A-2014-00703 Information regarding the medical device # 1256 and #1251S (class II), License number #62 by Benlan Inc. Disclosed in part 13
A-2014-00770 Information on penalties imposed as a result of audits/inspections of each pharmaceutical company and by category: number of incidents, number of recalls and associated risk types (I, II, III) for January 1, 2006, to September 30, 2014. All disclosed 207
A-2014-00907 Adverse Reaction Report (AER) for Flagyl (metronidazole). Report number: 000577502. Disclosed in part 5
A-2014-00910 Adverse Reaction Report (AER) for Plaquenil (hydroxychloroquine sulfate). Report number: 000528307. Disclosed in part 15
A-2014-00914 Adverse Reaction Report (AER) for Flagyl (metronidazole). Report number: 000591575. Disclosed in part 23
A-2014-00926 Adverse Reaction Report (AER) for Plaquenil (hydroxychloroquine sulfate). Report numbers: E2B_00044145, 000541170, 000533724 and 000577851 Disclosed in part 44
A-2014-00933 Adverse Reaction Report (AER) for Glucophage (metformin hydrochloride). Report number: 000553046. Disclosed in part 4
A-2014-00934 Adverse Reaction Report (AER) for Demerol (pethidine hydrochloride). Report number: 000551327. Disclosed in part 2
A-2014-00935 Adverse Reaction Report (AER) for Demerol (pethidine hydrochloride). Report number: 000551327. Disclosed in part 6
A-2014-00945 Adverse Reaction Report (AER) for ULORIC (febuxostat). Report numbers: 000583638, 000595647 and 000601655. Disclosed in part 7
A-2014-00952 Adverse Reaction Report (AER) for NORVIR. Report numbers: 000606212, E2B_00089567, 000606214 and E2B_00090618. Disclosed in part 23
A-2014-00968 Adverse Reaction Report (AER) for Demerol (pethidine hydrochloride). Report number: 000530677. Disclosed in part 2
A-2014-00995 Adverse Reaction Report (AER) for Sodium Iodide I131. Report number: 000339733. Disclosed in part 1
A-2014-01011 Documents under the Marihuana for Medical Purposes Regulations (MMPR) covering authorized producers: policies or procedures for processing applications; advertising restrictions; application processing timelines; schedule for granting authorizations or the maximum or anticipated number; inspection regulations or procedures; processing of security authorization applications; rejection of applications (Jan. 1, 2014, to Nov. 15, 2014) Disclosed in part 163
A-2014-01062 Adverse Reaction Report (AER) for Fludara (fludarabine phosphate). Report number: E2B_00091011. All disclosed 8
A-2014-01082 Records which capture or estimate any costs incurred by the federal government's representations pertaining to the case ALLARD v. Her Majesty the Queen in Right of Canada
and all of its proceedings to date, from the onset of the case in March 2014 up until and including the most recent court date of November 24, 2014
No records exist 0
A-2014-01114 Documents from the Sioux Lookout First Nations Authority related to the number of audited annual financial statements for fiscal years 2011 to 2014 inclusive. All disclosed 29
A-2014-01174 Copies of the following briefing materials provided to the Deputy Minister and listed by Ministerial Executive Correspondence System number:
  • 14-113402-19 – Privacy Act Annual Report
  • 14-112476-224 – Actions to Strengthen the Inspection Function
  • 14-112146-395 – Joint HC/PWGSC Audit of Nursing Services Contracts in Northern Manitoba
  • 14-111646-725 – Joint Work Plan to Improve the Health of First Nations in Alberta
  • 14-103111-394 – Import/Export Provisions of MMPR
All disclosed 13
A-2014-01221 Adverse Reaction Report (AER) for the following products/report numbers: Pantoloc (pantoprazole sodium) (000617889, 000620549, 000626749, 000627744, E2B_00142126), Tecta (pantoprazole magnesium) (000614580, 000619309, 000619631, 000620353, 000621924, 000624695, 000626742), Uloric (febuxostat) (000623943, 000627327, 000627154, Disclosed in part 43
A-2014-01222 Adverse Reaction Report (AER) for the following products/report numbers: Actos (pioglitazone) (000620486, 000617762), Alvesco (ciclesonide) (000615139, 000625145, E2B_00129652, E2B_00131206), Daxas (roflumilast) (000618305, 000624751, 000624981, 000627003, 000627384), Dexilant (dexlansoprazole) (000614420, 000615391, 000620844, 000623991, 000624750, 000624933, 000625761). Disclosed in part 68
A-2014-01231 Listing of the province, city and postal codes of all holders of an Authorization to Possess (ATP) licence under the Marihuana Medical Access Regulations (MMAR) program. Disclosed in part 662
A-2014-01284 Adverse Reaction Report (AER) for
Rythmol. Report number: E2B_00144071.
All disclosed 16
A-2014-01302 Adverse Reaction Report (AER) for Isoflurane. Report number: E2B_00121963. All disclosed 15
A-2014-01305 Adverse Reaction Report (AER) for Humira. Report numbers: E2B_00127783; E2B_00118762; and E2B_00127176. All disclosed 26
A-2014-01312 Adverse Reaction Report (AER) 000624854. Disclosed in part 4
A-2014-01313 Adverse Reaction Report (AER) 000625386. Disclosed in part 2
A-2014-01346 Copies of the following briefing materials listed by Ministerial Executive Correspondence System numbers:
  • 14-114373-413 - Consumer product safety and packaging re detergent pods
  • 14-114788-10 - Stakeholder meeting with Loblaws
  • 14-114554-779 - MMPR Quality Assurance Manager Security Application – fingerprints
Disclosed in part 18
A-2014-01349 Copy of the most recent list of constituents and emissions produced by tobacco companies. No records exist 0
A-2014-01364 All call-ups or contracts issued under the terms of the TBIPS Standing Offer and Supply Arrangement between the months of January 2014 to February 2014 and August 2014 to December 2014. Disclosed in part 1,448
A-2014-01390 Correspondence from the Parliamentary Secretary, Eve Adams, or her staff, regarding the Canadian Olympic Committee, the Olympics or government support for sports (May 2, 2011 to Feb 16, 2015) No records exist 0
A-2014-01392 Correspondence from the Member of Parliament, Eve Adams, or her staff, regarding Dimitri Soudas, Stampede Group or GTK Group (May 2, 2011 to Feb 16, 2015) No records exist 0
A-2014-01398 Copy of the Summary Basis of Decision and any supporting documents related to the approval of Ferriprox (deferiprone) by Health Canada No records exist 0
A-2014-01399 Information regarding the number of applications submitted, declined with notice, declined without notice and who made the final decision to decline the applications, under the Marihuana Medical Access Regulations program. All disclosed 1
A-2014-01409 Documents of all records of notification of health impairment and/or health effects submitted by the equipment owner the Canadian Auto Workers (CAW) and/or Unifor and by the manufacturer Enercon and its related entities for CAW wind turbine project in Port Elgin, Ontario (Mar. 25, 2013 to Feb. 16, 2015) No records exist 0
A-2014-01476 Labelling documents regarding ABILIFY MAINTENA (Aripiprazole), Drug Identification Numbers (DIN) 02420864 and DIN 02420872. No records exist 0
A-2014-01485 Information regarding the product "Move Free Advanced" (also "Move Free Advanced Triple Strength", marketed by Reckitt Benckiser (Canada) Inc. and its related literature case reports. Disclosed in part 16
A-2014-01491 Data in percentage and counts of the Canadian population smoking habits, by smoking status, quit attempts, smoke behaviour, education, age group (15+) and sex (1960 to 2014) No records exist 0
A-2014-01498 List of all companies that have received a Letter to Build or Permission to Proceed under the Marihuana for Medical Purposes Regulations (MMPR) Disclosed in part 1
A-2014-01509 List of all the studies conducted by the Applied Research and Analysis Directorate (Apr. 1, 2014 to Mar. 28, 2015) All disclosed 1
A-2014-01513 Adverse Reaction Report (AER) for Lovenox (enoxaparin sodium). Report number: 000617464. Disclosed in part 1
A-2014-01514 Adverse Reaction Report (AER) for Plavix (clopidogrel bisulphate). Report number: 000614678. Disclosed in part 1
A-2014-01544 With reference to the March 5, 2015 announcement of a financial assistance package for Canadian survivors of Thalidomide, any briefing notes for the Minister related to the March 2015 Department-Victims meetings, whether prepared before or after the meetings No records exist 0
A-2014-01545 With reference to the March 5, 2015 announcement of a financial assistance package for Canadian survivors of Thalidomide, any briefing notes for the Deputy Minister or Associate Deputy Minister related to the March 2015 Department-Victims meetings, whether prepared before or after the meetings No records exist 0
A-2014-01554 With reference to the March 5, 2015 announcement of a financial assistance package for Canadian survivors of Thalidomide, copies of communications received by the Department, excluding communications received from the victims and their organizations, the victim advocates, officials of other departments, media and researchers. (Jan. 2, 2012 to Dec. 31, 2014) No records exist 0
A-2014-01555 With reference to the March 5, 2015 announcement of a financial assistance package for Canadian survivors of Thalidomide, copies of communications related to Thalidomide received by the Department, excluding communications received from the victims and their organizations, the victim advocates, other Government of Canada officials, officials of other governments, media and researchers. (Jan. 1, 2015 and Mar, 25, 2015) No records exist 0
A-2014-01556 With reference to the March 5, 2015 announcement of a financial assistance package for Canadian survivors of Thalidomide, any briefing note prepared for the Minister on Motion M-546 of Ms. Libby Davis placed on Nov. 24, 2014 and withdrawn on Dec 10, 2014, or on the Opposition Motion on Survivors of Thalidomide of Ms. Davies placed on notice November 25, debated November 27 and adopted by the House of Commons on December 1, 2014 No records exist 0
A-2014-01558 With reference to the March 5, 2015 announcement of a financial assistance package for Canadian survivors of Thalidomide, any briefing notes prepared for the Parliamentary Secretary to the Minister on Motion M-546 or on the Opposition Motion on Survivors of Thalidomide No records exist 0
A-2014-01559 With reference to the March 5, 2015 announcement of a financial assistance package for Canadian survivors of Thalidomide, any briefing notes prepared for the Deputy Minister or Associate Deputy Minister on Motion M-546 or on the Opposition Motion on Survivors of Thalidomide No records exist 0
A-2014-01563 With reference to the March 5, 2015 announcement of a financial assistance package for Canadian survivors of Thalidomide, any other briefing notes related to Thalidomide prepared for the Minister, Deputy Minister or Associate Minister in 2013 No records exist 0